InpharmD synthesizes the latest clinical evidence with each payer's policy and your formulary economics—so prescribers, P&T committees, and authorization teams act on one source of truth.
No team can keep pace with all of them by hand. InpharmD watches every signal, every day, across every drug class.
New drugs, new indications, and new generic and biosimilar entrants launch every quarter—each with its own evidence and economics.
Guidelines, label updates, and head-to-head trial data are revised constantly—what was first-line last quarter may not be today.
Step-therapy rules, prior-auth criteria, and contract terms change throughout the year across hundreds of plans.
WAC, ASP, 340B, and rebate dynamics swing margin per encounter—often without notice and across every therapeutic class.
Match clinical evidence to insurance, formulary, and procurement in seconds.
Cut prior-auth friction with payer-specific routing built into the workflow.
Skip notifications for non-covered products and protect prescriber attention.
Lift reimbursement on any therapy with full transparency into payer rules.